Pharma Mar SA

(PHMMF)

By |

Profile

Pharma Mar SA develops and commercializes YONDELIS in Europe and has three clinical-stage programs under development, in addition to trabectedin, for several types of solid and hematological cancers, PM1183, plitidepsin, and PM60184.

Contact Information

Website: www.pharmamar.com
Email: info_ri@zeltia.com
Main Phone: +34 918466000
Address: Avda. De los Reyes, 1
Address 2: Pol. Ind. La Mina
City / Town: Madrid
Country: ESP
Postal Code: 28770

Issuer Information

Exchange: OTO
Employees: 700
$ 2.00 $ -0.05 (-2.44%)
Last Price 2.00 Change $ -0.05 Change % -2.44 Tick N/A
Bid N/A Bid Size N/A Ask N/A Ask Size N/A
Open 2.04 High 2.04 Low 2.00 Prev Close 2.05
Last Trade Volume 10,246 52 Wk Hi 4.80 52 Wk Low 1.84
Market Cap 441.6 mi Ex-Div Date N/A Div Rate N/A Yield N/A
Shares 220,785,537.00 EPS (TTM) -0.11 PE Ratio N/A Exchange OTCPK